29.03.2016 • NewsElaine BurridgeEvonikcapacity expansion

Evonik Begins Silicones Project in China

Evonik has broken ground on a new plant to produce organically modified specialty silicones in China. The project is part of a global silicones expansion program that the German company announced in March 2015.

The facility is located on the Multi-User-Site (MUSC) in the Shanghai Chemical Industry Park and completion is planned for the middle of 2017. Capacity details were not disclosed but investment costs were put in the high double-digit million euro range.

Klaus Engel, chairman of Evonik’s executive board, said the company wanted to expand specialty silicones capacity in Asia to serve rising demand with local production.

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.